Related Experiment Video
Updated: Jun 10, 2026
05:36
Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
Published on: October 4, 2024
[The premenstrual syndrome].
Femke van der Leij1, Willibrord C M Weijmar Schultz, Harry van de Wiel
1St. Antonius Ziekenhuis, Nieuwegein, Afd. Gynaecologie, the Netherlands. fleij@hotmail.com
Nederlands Tijdschrift Voor Geneeskunde
|August 20, 2010
Summary
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) involve cyclical symptoms. Selective serotonin reuptake inhibitors and specific oral contraceptives show promise for managing PMS and PMDD symptoms.
Area of Science:
- Gynecology
- Psychiatry
- Endocrinology
Context:
- Premenstrual syndrome (PMS) affects women during the luteal phase, resolving with menstruation.
- Premenstrual dysphoric disorder (PMDD) is a severe variant of PMS, marked by psychological symptoms.
- The exact causes of PMS and PMDD remain unknown, but hormonal fluctuations are implicated.
Purpose:
- To review the characteristics, diagnosis, and treatment of PMS and PMDD.
- To explore potential etiological factors, including abnormal responses to hormonal changes.
- To assess the efficacy of treatments for PMS and PMDD.
Summary:
- PMS and PMDD are defined by cyclical physical and psychological symptoms.
- Diagnosis requires prospective daily symptom monitoring over two menstrual cycles.
- Selective serotonin reuptake inhibitors and oral contraceptives with drosperinone demonstrate positive effects in clinical trials.
Impact:
- Highlights the need for effective treatment options for PMS and PMDD.
- Suggests pharmacological interventions for symptom management.
- Informs clinical practice regarding diagnosis and treatment of these conditions.
Related Concept Videos
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:19The Menstrual Cycle
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a uterine...
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a uterine...
01:18Menses Phase
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:19Secretory Phase
The secretory phase of the menstrual cycle, spanning from day 14 to 28 in a typical 28-day cycle, is a period of significant physiological changes in the female reproductive system. This phase commences immediately after ovulation and is characterized by the preparation of the endometrium for potential embryo implantation.
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...